---
title: "NeuroOne Medical Market Development Director Mark Christianson sells 10,000 shares for $31,773"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291587390.md"
description: "NeuroOne Medical Technologies Market Development Director Mark Christianson sold 10,000 common shares on June 30 at a price of $3.18 per share, totaling $31,773. Following the transaction, Christianson retained a holding of 20,692 shares. The information was published via EDGAR by NeuroOne Medical Technologies Corporation."
datetime: "2026-07-02T20:41:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291587390.md)
  - [en](https://longbridge.com/en/news/291587390.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291587390.md)
generator: "portal-rs"
---

# NeuroOne Medical Market Development Director Mark Christianson sells 10,000 shares for $31,773

-   NeuroOne Medical Technologies Market Development Director Mark Christianson sold 10,000 common shares on June 30. \* Sale price was USD 3.18 per share. \* Christianson held 20,692 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuroone Medical Technologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001709738-26-000010), on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [NMTC.US](https://longbridge.com/en/quote/NMTC.US.md)

## Related News & Research

- [NeuroOne reports successful large-animal procedures using next-generation StereoCED platform](https://longbridge.com/en/news/297191400.md)
- [Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing](https://longbridge.com/en/news/297194419.md)
- [NeuroOne Advances StereoCED Toward Human Clinical Studies](https://longbridge.com/en/news/297210429.md)
- [BNY Mellon Senior Executive VP Jose Minaya sells common shares worth $572,074.74](https://longbridge.com/en/news/297557354.md)
- [Antelope Enterprise announces private placement of unregistered Class A ordinary shares](https://longbridge.com/en/news/297327460.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**